Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion type Assertion NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_head.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion description "[The SRC-ABL inhibitor bosutinib is one of the five tyrosine kinase inhibitors currently approved for the treatment of Philadelphia chromosome-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_provenance.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion evidence source_evidence_literature NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_provenance.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion SIO_000772 24490604 NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_provenance.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion wasDerivedFrom befree-20150227 NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_provenance.
- NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_assertion wasGeneratedBy ECO_0000203 NP712097.RA_-9CiUXIbTCVsgqcgV5Ef_UWGqRVAiWI5Mt7CZVYcmw130_provenance.